Dr. Allison Estes Rizzuti, MD

Dr. Rizzuti practices at NYC Health + Hospitals/South Brooklyn Health, Ruth Bader Ginsburg Hospital in Brooklyn, New York, part of NYC.

Dr. Rizzuti's NPI, 1003130972, was assigned on March 22, 2010. Dr. Rizzuti holds New York license 265079.

Dr. Rizzuti's primary practice is NYC Health + Hospitals/South Brooklyn Health, Ruth Bader Ginsburg Hospital, at 2601 Ocean Parkway, Brooklyn, NY 11235 in Kings County. The practice phone is (718) 616-4834.

Dr. Rizzuti's primary practice is NYC Health + Hospitals/South Brooklyn Health, Ruth Bader Ginsburg Hospital in Brooklyn, New York, part of NYC. Dr. Rizzuti is also affiliated with NYC Health + Hospitals/Kings County. The medical group on file is Physician Affiliate Group of New York (PAGNY). Dmand AI also links Dr. Rizzuti to 4 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rizzuti practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Rizzuti's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Rizzuti is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Rizzuti is licensed in New York.

CMS data shows 98 Medicare services from Dr. Rizzuti across 3 procedure codes in 2024, for 91 Medicare patients. Medicare paid $3,994 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 91 Medicare patients who saw Dr. Rizzuti in 2024. The largest group is 65 to 74, with 36 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 74% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rizzuti's median patient age at 73, with 59% women.

In 2024, Dr. Rizzuti wrote 21 Medicare Part D claims. 71% of them were for generic drugs. CMS names the drug for 18 of them, across 1 drug with 11 or more claims each, at $288 in total drug cost. In 2020, CMS named 194 claims across 5 drugs.

Dr. Rizzuti accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Rizzuti, published from 2013 to 2017. 2013 was the busiest year, with 2. Dr. Rizzuti has published most often in Cornea. Dr. Rizzuti's most frequent co-authors are Douglas R. Lazzaro, MD, Roman Shinder, MD and Steven A. Agemy, MD.

CMS Open Payments shows 40 general payments to Dr. Rizzuti from 10 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Alcon Laboratories Inc paid the most, $1,161.